Oracle Institutional Partners L P - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Oracle Institutional Partners L P. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Oracle Institutional Partners L P has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Oracle Institutional Partners L P. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ABEO / Abeona Therapeutics Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ABEO / Abeona Therapeutics Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2008-02-12	ACCP	FEINBERG LARRY N	29,736	3.1500	29,736	3.1500	93,668	731
2007-06-19	ACCP	FEINBERG LARRY N	60,000	5.1700	60,000	5.1700	310,200
2007-01-22	ACCP	FEINBERG LARRY N	6,040	2.5300	6,040	2.5300	15,281
2005-12-31	ACCP	FEINBERG LARRY N	15,636	0.6500	15,636	0.6500	10,163
2005-12-31	ACCP	FEINBERG LARRY N	82,745	0.6500	82,745	0.6500	53,784
2005-12-31	ACCP	FEINBERG LARRY N	299,056	0.6500	299,056	0.6500	194,386
2005-12-31	ACCP	FEINBERG LARRY N	78,184	0.6500	78,184	0.6500	50,820
2005-02-01	ACCP	FEINBERG LARRY N	30,200	2.6900	30,200	2.6900	81,238

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales ABEO / Abeona Therapeutics Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ABEO / Abeona Therapeutics Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2008-02-12	ACCP	FEINBERG LARRY N	29,736	3.1500	29,736	3.1500	93,668	731
2007-07-24	ACCP	FEINBERG LARRY N	2,040	4.3500	2,040	4.3500	8,874
2007-07-23	ACCP	FEINBERG LARRY N	4,000	4.3563	4,000	4.3563	17,425
2007-06-19	ACCP	FEINBERG LARRY N	40,000	5.1700	40,000	5.1700	206,800
2007-06-19	ACCP	FEINBERG LARRY N	20,000	5.1700	20,000	5.1700	103,400
2007-03-01	ACCP	FEINBERG LARRY N	1,200	7.1250	1,200	7.1250	8,550
2007-02-28	ACCP	FEINBERG LARRY N	10,000	7.1000	10,000	7.1000	71,000
2007-02-28	ACCP	FEINBERG LARRY N	4,500	7.1000	4,500	7.1000	31,950
2007-02-27	ACCP	FEINBERG LARRY N	300	7.0000	300	7.0000	2,100
2007-02-27	ACCP	FEINBERG LARRY N	100	7.0000	100	7.0000	700
2007-02-26	ACCP	FEINBERG LARRY N	19,000	7.3140	19,000	7.3140	138,966
2007-02-26	ACCP	FEINBERG LARRY N	5,000	7.3140	5,000	7.3140	36,570
2007-02-26	ACCP	FEINBERG LARRY N	1,000	7.3140	1,000	7.3140	7,314
2007-01-22	ACCP	FEINBERG LARRY N	6,040	2.5300	6,040	2.5300	15,281
2006-09-01	ACCP	FEINBERG LARRY N	1		1
2006-09-01	ACCP	FEINBERG LARRY N	0		0
2006-09-01	ACCP	FEINBERG LARRY N	0		0
2005-02-01	ACCP	FEINBERG LARRY N	30,200	2.6900	30,200	2.6900	81,238

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases AWHL / Aspira Women's Health Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ABEO / Abeona Therapeutics Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2017-02-17	VRML	FEINBERG LARRY N	617,731	1.4000	617,731	1.4000	864,823	304
2015-07-14	VRML	FEINBERG LARRY N	510,204	1.9600	510,204	1.9600	1,000,000
2015-07-14	VRML	FEINBERG LARRY N	1,839	1.9054	1,839	1.9054	3,504
2014-12-23	VRML	FEINBERG LARRY N	972,222	1.4400	972,222	1.4400	1,400,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales AWHL / Aspira Women's Health Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ABEO / Abeona Therapeutics Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Oracle Institutional Partners L P as disclosed to the Securities Exchange Commission (SEC).